Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
European Child & Adolescent Psychiatry · 2025
DOI: 10.1007/s00787-024-02587-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Celso Arango und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIB…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Acetamides, Fluoxetine, Antidepressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Servier France.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
- Universitätsklinikum Ulm, Steinhövelstraße 5, 89075, Ulm, Germany.
- Servier Medical and Patient Affairs, Suresnes, France.
- Servier Forschung und Pharmaentwicklung, Munich, Germany. ute.marx@servier.com.
- Servier Global Biometrics, Suresnes, France.
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
Förderung
- Servier France
Zitieren
APA
Arango, C., Fegert, J. M., Picarel-Blanchot, F., Marx, U., Truffaut-Chalet, L., Pénélaud, P. F., Buitelaar, J., & study investigators (2025). Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-024-02587-4
Vancouver
Arango C, Fegert JM, Picarel-Blanchot F, Marx U, Truffaut-Chalet L, Pénélaud PF, et al. Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-024-02587-4
BibTeX
@article{Arango2025,
author = {Arango, Celso and Fegert, Joerg M and Picarel-Blanchot, Françoise and Marx, Ute and Truffaut-Chalet, Lucie and Pénélaud, Pierre-François and Buitelaar, Jan and study investigators, study investigators},
title = {Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study},
journal = {European Child & Adolescent Psychiatry},
year = {2025},
doi = {10.1007/s00787-024-02587-4}
}
EUVIMED